2025. The Autologous CaTeVac Dendritic Cell Vaccine in Patients with Melanoma: Final Results of the DENDRON-01 Study. Voprosy onkologii. 71, 4 (Sep. 2025), OF-2437. DOI:https://doi.org/10.37469/0507-3758-2025-71-4-OF-2437.